Heart-Failure Experts To Offer Rare Historic Review Of Condition, Therapy, And Diversity In Chicago
Chronic cardiac disease is documented as far back as ancient Egypt. While morbidity rates have decreased markedly and solution options have advanced substantially in the last 50 years, in the U.S. alone nearly 5 million people still suffer from heart failure and another 550,000 more join the group each year. The History of Heart Failure Project aims to improve patient health and outcomes with highly effective, specialized insight from the medical community, for the medical community.
On March 31st, four renowned cardiac physicians will deliver four unique assessments of heart-failure documentation, research, and solutions; they are:
- Hector Ventura -- Chairman, Graduate Medical Education, Section Head, Heart Failure/Transplantation, Ochsner Heart & Vascular Institute, Associate Professor, Medicine, Louisiana State University School of Medicine, Professor, Medicine, Tulane University School of Medicine -- "The First Writings of Heart Failure."
- Kirkwood Adams -- Associate Professor, Medicine & Radiology -- Cardiology, University of North Carolina at Chapel Hill, Transplant Cardiologist & Director, Heart Failure Program -- "Good and Bad Adaptation: History of Hypertrophy -- Muscle to Matrix."
- Jim Young -- Chairman, Medicine, Cleveland Clinic Foundation, Professor, Medicine, and Academic Chairman, Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Medical Director, Cleveland Clinic Kaufman Center for Heart Failure -- "Modern Therapies & Interventions."
Clyde Yancy -- Medical Director, Baylor Heart & Vascular Institute, Chief of Cardiothoracic Transplantation, Baylor University Medical Center in Dallas -- "The History of Diversity in Cardiovascular Research."
Laura McCaskill, President & CEO of MEDAVERA, Inc., event co-sponsor, stated, "As a condition, heart failure has survived thousands of years. While the medical community has made remarkable progress in staying disease impact, new occurrences of the disease remain steady, challenging us to reach further and innovate farther. We are thrilled to have the opportunity to learn from such a distinctive forum of experts. The exceptional knowledge and perspective that will be disseminated in one evening is uncommon, even today. And, reaffirming medical science in full chronological and cultural context surely boosts our societal ability to meet a truly human cause."
"A History of Heart Failure: A Journey from Ancient Therapies to Modern Interventions," will occur from 7pm-9pm Central, Monday, March 31, 2008, in the Empire Room of the Palmer House Hilton in Chicago, Illinois. Individuals attending the session are eligible for Continuing Medical Education credits through Educational Review Systems. The event is jointly sponsored by MEDAVERA, Inc., and the Medical Teaching Foundation, Inc., with unrestricted, non-vendor-biased educational grant support from Amgen, Biosite, Inc., CHF Solutions, Otsuka America Pharmaceutical, and ResMed.
While not directly associated with ACC.08 (occurring March 29th to April 1st in Chicago), the "History of Heart Failure" event is intended to occur in parallel with ACC.08 in order to bestow additional useful knowledge to the convened medical community. The event is not part of the official ACC Annual Scientific Session and/or the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit as planned by their Program Committees.
About The History of Heart Failure Project
The History of Heart Failure Project is a collaborative educational effort designed to improve future patient care by enhancing medical professional understanding of historic and modern factors. For more information about The History of Heart Failure Project, please visit http://www.hfhistory.com.
About MEDAVERA, Inc.
MEDAVERA is a medical education company headquartered in Springfield, MO. The company mission is to improve patient health by identifying educational need and transferring medical knowledge with superior communication strategies and tools. For more information about MEDAVERA, please visit http://www.medavera.com.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed herein are forward-looking, reflect numerous assumptions, and involve risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect changes in events or circumstances arising after the date hereof.
MEDAVERA, Inc.
Heart-Imposibilitatea de experþi pentru a Oferta Rare istorice revizuirea condiþie, terapie, ºi diversitãþii în Chicago - Heart-Failure Experts To Offer Rare Historic Review Of Condition, Therapy, And Diversity In Chicago - articole medicale engleza - startsanatate